Lead Physician
US Food and Drug Administration (FDA) /Center for Biologics Research and Evaluation (CBER)
Silver Spring, MD
Dr. Rosa Sherafat is a board-certified pediatric endocrinologist and a lead physician in Office of Therapeutic Products (OTP), in the FDA Center for Biologics Evaluation and Research (CBER). Dr. Sherafat received her medical degree from Tehran University of Medical Sciences, completed residency in pediatrics at University of Illinois Medical Center, Chicago, IL and fellowship in pediatric endocrinology in Cincinnati Children’s Hospital, Cincinnati, OH. She has been an associate professor of pediatrics in the Department of Pediatrics, Medstar Georgetown University Hospital, Washington, DC (2007-2018).
Dr. Sherafat served as the clinical co-chair and FDA speaker at the 70th Meeting of the Cellular, Tissue, and Gene Therapies (CTGT) Advisory Committee Meeting on Toxicity Risks of AAV Vector-Based Gene Therapy Products (September 2-3, 2021). She participated in the revision of the FDA Guidance for Industry, Long Term Follow Up after Administration of Human Gene Therapy Products (January 2020) and has represented CBER in the FDA Inter-Center Wound Healing Endpoints Working Group and is a member of CBER Pediatric Working Group.
Disclosure information not submitted.
Saturday, April 29, 2023
9:15 AM – 10:15 AM